Another promising therapeutic target for preventing COPD has been identified in Lnc-HOTAIR; in fact, a reduction in its expression may lead to decreased apoptosis by enhancing Bcl-2 production in the lung [35]. This evidence concerns the gene BCL2 and chronic obstructive pulmonary disease.